MarketScreener Editorial Features Guard Therapeutics International AB
Equities
GUARD
SE0021181559
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.80 SEK | -0.69% | -0.69% | -19.55% |
08-29 | First Patient Dosed in Guard Therapeutics' Phase 2B Study POINTER | CI |
08-27 | Guard Therapeutics Plans New SEK80 Million Rights Issue to Fund Kidney Drug Study | MT |
- Stock Market
- Equities
- GUARD Stock
- News Guard Therapeutics International AB
- MarketScreener Editorial Features
MarketScreener is also available in this country: United States.
Switch edition